An American patient diagnosed with the coronavirus (COVID-19) has been given a treatment by Israeli-based Pluristem that, so far, has a 100 percent survival rate.
Israeli startup Intensix is trialing an Intensive Care Unit patient monitoring system, which gives an early warning of impending sepsis and organ failure that kills 30% of ICU patients, and scientists at Israel’s Technion have discovered how to use proteins to suppress unwanted gene activity.
As Israel’s political parties fight another election and form alliances in its aftermath, here are some other perhaps more constructive battles that the Jewish State has been fighting recently.
Join More than
11,466,096
United With Israel
You will receive updates from Israel (see privacy policy)
